Valuation : BOIRON

Market Cap 439M 510M 412M 376M 708M 48.72B 711M 4.89B 1.91B 24.59B 1.91B 1.87B 81.55B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 391M 454M 367M 335M 631M 43.41B 633M 4.35B 1.7B 21.91B 1.71B 1.67B 72.66B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week-1.17%
Current month-5.95%
1 month-6.30%
3 months-8.33%
6 months-6.30%
Current year-15.10%
1 week 25.3
Extreme 25.3
26.2
1 month 25.3
Extreme 25.3
27.4
Current year 24.6
Extreme 24.6
30.25
1 year 20.95
Extreme 20.95
31.35
3 years 20.65
Extreme 20.65
56.6
5 years 20.65
Extreme 20.65
56.6
10 years 20.65
Extreme 20.65
92.52
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.17% - - 510M
+0.02%+1.36%-13.16%-7.68% 13.26B
+0.53%+2.99%-31.39%-55.80% 4.99B
+0.27%+1.59%-5.32%-4.34% 4.66B
-0.43%-1.64%-1.22%-30.17% 4.02B
+0.08%+3.06%-20.99%+4.77% 3.59B
-0.67%+2.71%-2.98%-4.10% 3.43B
+0.47%-0.53%-9.87%+7.51% 3.31B
-2.19%-2.26%-22.25%-13.02% 2.38B
+0.74%+2.97%-26.78%-14.44% 1.72B
Average -0.12%+1.90%-14.88%-13.03% 4.6B
Weighted average by Cap. -0.05%+1.73%-13.98%-13.29%

Financials

2024 2025
Net sales 488M 566M 457M 417M 786M 54.08B 789M 5.42B 2.12B 27.3B 2.12B 2.08B 90.51B 501M 582M 470M 429M 808M 55.58B 811M 5.57B 2.17B 28.06B 2.18B 2.14B 93.03B
Net income 11.34M 13.16M 10.63M 9.7M 18.28M 1.26B 18.34M 126M 49.2M 635M 49.39M 48.32M 2.1B 32.64M 37.88M 30.61M 27.94M 52.63M 3.62B 52.8M 363M 142M 1.83B 142M 139M 6.06B
Net Debt -49.74M -57.72M -46.63M -42.57M -80.2M -5.52B -80.45M -553M -216M -2.78B -217M -212M -9.23B -47.86M -55.54M -44.87M -40.96M -77.16M -5.31B -77.41M -532M -208M -2.68B -209M -204M -8.88B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change
26-08-28 €25.30 0.00%
26-08-27 €25.30 -3.44%
26-08-26 €26.20 +2.34%
26-08-25 €25.60 -0.39%
26-08-24 €25.70 +0.39%

Annual profits - Rate of surprise